These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22708940)

  • 1. Hearing in bisphosphonate-treated children with osteogenesis imperfecta: our experience in thirty six young patients.
    Ting TH; Zacharin MR
    Clin Otolaryngol; 2012 Jun; 37(3):229-33. PubMed ID: 22708940
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception.
    Chen CP; Lin SP; Su YN; Huang JP; Chern SR; Su JW; Wang W
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):305-7. PubMed ID: 22795118
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonate treatment of children and adults with osteogenesis imperfecta: unanswered questions.
    Brizola E; Shapiro JR
    Calcif Tissue Int; 2015 Aug; 97(2):101-3. PubMed ID: 26071113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function tests in an infant with osteogenesis imperfecta and early biphosphonate treatment.
    Rugolotto S; Monti E; Carli M; Pietrobelli A; Antoniazzi F; Tato L
    Acta Paediatr; 2007 Dec; 96(12):1856-7. PubMed ID: 18001342
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta.
    Bhadada SK; Santosh R; Bhansali A; Upreti V; Dutta P
    J Assoc Physicians India; 2009 Jan; 57():33-6. PubMed ID: 19753756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta.
    Huber MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hearing is not affected by diphosphonates in osteogenesis imperfecta. Retrospective study of 42 medical records].
    Brodd I; Hederstierna C; Sääf M; Hultcrantz M
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1906-9. PubMed ID: 22111228
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C
    Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged bisphosphonate release after treatment in children.
    Papapoulos SE; Cremers SC
    N Engl J Med; 2007 Mar; 356(10):1075-6. PubMed ID: 17347467
    [No Abstract]   [Full Text] [Related]  

  • 11. Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle.
    Tsimicalis A; Boitor M; Ferland CE; Rauch F; Le May S; Carrier JI; Ngheim T; Bilodeau C
    Eur J Pediatr; 2018 Jun; 177(6):891-902. PubMed ID: 29637375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate treatment in children with osteogenesis imperfecta.
    Akcay T; Turan S; Guran T; Bereket A
    Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].
    Chigladze TT; Zhvaniia MA; Bekua MV
    Georgian Med News; 2006 Feb; (131):62-5. PubMed ID: 16575136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta.
    Garganta MD; Jaser SS; Lazow MA; Schoenecker JG; Cobry E; Hays SR; Simmons JH
    BMC Musculoskelet Disord; 2018 Sep; 19(1):344. PubMed ID: 30249227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.
    Shapiro JR; Thompson CB; Wu Y; Nunes M; Gillen C
    Calcif Tissue Int; 2010 Aug; 87(2):120-9. PubMed ID: 20544187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H; Rodrigues JM; Radonsky V; Della Manna T; Kuperman H; Steinmetz L; Dichtchekenian V; Damiani D; Setian N
    Horm Res; 2007; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta and hearing loss.
    Cohen BJ
    Ear Nose Throat J; 1984 Jun; 63(6):283-8. PubMed ID: 6745130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.